Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-06-07
2005-06-07
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S185100, C424S190100, C424S234100, C424S257100, C530S350000
Reexamination Certificate
active
06902736
ABSTRACT:
Compositions comprising products of the csa operon, an isolated nucleic acid encoding the csa operon or functional fragments thereof, purified polypeptide products of the csa operon or functional fragments thereof, methods of eliciting an immune response to these products, and methods of producing products of the csa operon are disclosed herein.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5417986 (1995-05-01), Reid et al.
patent: 5932715 (1999-08-01), Scott et al.
patent: 6110898 (2000-08-01), Malone et al.
patent: 6187344 (2001-02-01), Eljamal et al.
patent: 6190669 (2001-02-01), Noriega et al.
patent: WO 96 38171 (1996-12-01), None
Bowie et al., Science, vol. 247 No. 4948, pp. 1306-1310 (1990).
Abaza et al., Journal of Protein Chemistry, vol. 11 No. 3, pp. 433-444 (1992).
Riffkin et al., Gene, vol. 167, pp. 279-283 (1995).
CancerWEB Online Medical Dictionary, “gene product”, 2002.
Watson et al.. Recombinant DNA, Scientific American Books, N.Y., 1992.
Lodish et al., Molecular Cell Biology, Third Edition, pp. 252-254, Scientific American Books, Inc., 1995.
Freedman DJ, et al. Milk Immunoglobulin with Specific Activity against Purified Colonization Factor Antigens Can Protect against Oral Challenge with EnterotoxigenicEscherichia coli. J. Infect. Disease177:662-667 (1998).
Levine, MM, et al. Immunity to EnterotoxigenicEscherichia coli. Infect. Immun. 23:729-736 (1979).
Altboum, Z, et al. Genetic Characterization and Immunogenicity of Coli Surface Antigen 4 from EnterotoxigenicEscherichia coliwhen it is Expressed in a Shigella Live-Vector Strain.Infect. Immun. 71:1352-1360 (2003).
Scott, JR, et al. CooB is required for assembly but not transport of CS1 pilin.Mol. Micro. 6(3):293-300 (1992).
Altboum et al. (2001) Attenuated Shigella flexneri 2a ΔguaBA strain CVD 1204 expressing enterotoxigenicEscherichia coli(ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against shigella and ETEC infection. Infection and Immunity. 69(5):3150-3158.
Black et al. (1981) EnterotoxigenicEscherichia colidiarrhoea: acquired immunity and transmission in an endemic area. Bulletin of the World Health Organization. 59(2):263-268.
Black, R.E. (1986) Pathogens that cause travelers' diarrhea in Latin America and Africa. Reviews of Infectious Diseases. 8(2):S131-S135.
Blomfield, et al. (1991) Allelic exchange inEscherichia coliusing the bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Molecular Microbiology. 5(6):1447-1457.
Bolivar, et al. (1977) Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene. 2:95-113.
Chang et al. (1978) Phenotypic expression inE. coliof a DNA sequence coding for mouse dihydrofolate reductase. Nature. 275:617-624.
Cote, et al. (1983) Generation of human monoclonal antibodies reactive with cellular antigens. Proc.Natl.Acad.Sci. 80:2026-2030.
deHaan et al. (1991) The nucleotide sequence of a regulatory gene presnet on a plasmid in an enterotoxigenicEscherichia colistrain of serotype O167:H5. FEMS Microbiology Letters 83. 341-346.
DuPont, et al. (1976) Comparative susceptibility of Latin American and united states students to enteric pathogens. New England Journal of Mecicine. 1520-1521.
Duthy et al. (1999) CS5 pilus biosynthesis genes from enterotoxigenicEscherichia coliO115:H40. Journal of Bacteriology. 181(18):5847-5851.
deBoer et al. (1983) The tac promoter: A functional hybrid derived from the trp and lac promoters. Proc.Natl.Acad.Sci. 80:21-25.
Engvall, E. (1980) Enzyme immunoassay ELISA and EMIT. Meth. Enzymol. 70:419-439.
Felgner et al. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc.Natl.Acad.Sci. 84:7413-7417.
Fraley et al. (1981) New generation liposomes: the engineering of an efficient vehicle for intracellular delivery of nucleic acids. TIBS. 77-80.
Froehlich et al. (1994) CooC and CooD are required for assembly of CS1 pili. Molecular Microbiology. 12(3):387-401.
Froehlich et al. (1995) Genes for CS2 pili of enterotoxigenicEscherichia coliand their interchangeability with those for CS1 pili. Infection and Immunity. 63(12):4849-4856.
Gaastra et al. (1996) Colonization factors of human enterotoxigenicEscherichia coli(ETEC) Trends in Microbiology. 4(11):444-452.
Galen et al. (1999) Optimization of plasmid maintenance in the attenuated live vector vaccine strain salmonella typhi CVD 908-htrA. Infection and Immunity. 67(12):6424-6433.
Goeddel et al. (1979) Direct expression inEscherichia coliof a DNA sequence coding for human growth hormone. Nature. 281:544-548.
Goeddel et al. (1980) Synthesis of human fibroblast interferon byE. coli. Nucleic Acids Research. 8(18):4057-4075.
Grewal et al. (1993) Induction of colonization factor antigen I(CFA/I) and coli surface antigen 4(CS4) of enterotoxigenicEscherichia coli: relevance for vaccine production. Vaccine. 11(2):221-226.
Hall et al. (1989) Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenicEscherichia coli. Journal of Bacteriology. 171(11):6372-6374.
Hamers et al. (1989) The nucleotide sequence of the first two genes of the CFA/I fimbrial operon of human enterotoxigenicEscherichia coli. Microbial Pathogenesis. 6:297-309.
Hitzeman, et al. (1980) Isolation and characterization of the yeast 3-phosphoglycerokinase gene (PGK) by an immunological screening technique. The Journal of Biological Chemistry. 255(24):12073-12080.
Holland et al. (1978) Isolation and Identification of yeast messenger ribonucleic acids coding for enolase, glyceraldehyde-3-phosphast dehydrogenase, and phosphoglycerate kinase. Biochemistry. 17(23):4900-4907.
Huse, et al. (1989) Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science. 246:1275-1281.
Hyams et al. (1991) Diarrheal disease during operating desert shield. The New England Journal of Medicine. 325(20)1423-1428.
Jalajakumari, et al. (1989) Genes for biosynthesis and assembly of CS3 pili of CFA/II enterotoxigenicEscherichia coli: novel regulation of pilus production by bypassing an amber codon. Molecular Microbiology. 3(12):1685-1695.
Jaye et al. (1983) Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Research. 11(8):2325-2335.
Jertbom et al. (1998) Safety and immunogenicity of an oral inactivated enterotoxigenicEscherichia colivaccine. Vaccine. 16(2/3):255-260.
Knutton et al. (1989) Adhesion and ultrastructural properties of human enterotoxigenicEscherichia coliproducing colonization factor antigens III and IV. Infection and Immunity. 57(11):3364-3371.
Kohler et al. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
Koprowski II et al. (2000) AttenuatedShigella flexneri2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenicEscherichia coli. Infection and Immunity. 68(9):4884-4892.
Kotloff et al. (1995) Evaluation of the safety, immunogenicity, and efficacy in healthy adults of our doses of live oral hybridEscherichia coli-Shigella flexnera2a vaccine strain EcSf2a-2. Vaccine. 13(5):495-502.+.
Levine et al. (1984) Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenicEscherichia coli: morphology, purification, and immune responses in humans. Infection and Immunity. 44(2):409-420.
Levine, M.M. (1987)Escherichia colithat cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. The Journal of Infectious Diseases. 377-389.
Levine, M.M. (2000) Immunization against bacterial diseases of the intestine. Journal of Pediatric Gastroenterology and Nutrition. 31:336-355.
Manning, et al. (1985) Colonization factor antigen II (CFA/II) of enterotoxigenicEscherichia coli: molecular cloning of the CS3 determinant. Mol.Gen.Genet. 200:322-327.
Mannino et al. (1988) Liposome mediated gene transfer. BioTechn
Altboum Zeev
Barry Eileen M.
Levine Myron M.
Lucas Zachariah
University of Maryland Baltimore
LandOfFree
Isolation and characterization of the csa operon (ETEC-CS4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation and characterization of the csa operon (ETEC-CS4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and characterization of the csa operon (ETEC-CS4... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480333